5-Phenyl-2,4-benzodiazepines
AssigneeYeda Research and Development Co. Ltd.
InventorsWilliam Taub, Uri Golik
Life of this patent
Estimating the term…
Abstract
5-Phenyl-2,4-benzodiazepines useful as psychotropic agents and their pharmaceutically acceptable salts and N-oxides, procedure for their production and oral dosage unit pharmaceutical compositions containing said agents.
Claims10
A compound of the formula (I):
- ##SPC5##
- or a pharmaceutically acceptable salt or N-oxide thereof wherein R.sub.1 is a hydrogen or halogen atom or a nitro, methyl, cyano or trifluoromethyl group;
- R.sub.2 is a hydrogen or halogen atom or a nitro, methyl, cyano or trifluoromethyl group;
- R.sub.3 is a hydrogen atom or a methyl group;
- R.sub.4 is a hydrogen atom or a methyl or ethyl group.
A compound of the formula ##SPC6##
- wherein R.sub.1 is a fluorine, chlorine, nitro or trifluoromethyl group, or a pharmaceutically acceptable acid addition salt or N-oxide thereof.
5-Phenyl-2,3-dihydro-1H-2,4-benzodiazepine-1-one or a pharmaceutically acceptable acid addition salt.
5-Phenyl-2,3-dihydro-1H-2,4-benzodiazepine-1-one-4-oxide.
5-Phenyl-2,3-dihydro-1H-2,4-(7-chlorobenzodiazepine)-1-one or a pharmaceutically acceptable acid addition salt.
5-Phenyl-2,3-dihydro-1H-2,4-(7-chlorobenzodiazepine)-1-one-4-oxide.
5-Phenyl-2,3-dihydro-1H-2,4-(7-nitrobenzodiazepine)-1-one or a pharmaceutically acceptable acid addition salt.
5-Phenyl-2,3-dihydro-1H-2,4-(7-nitrobenzodiazepine)-1-one.
Dependencies are inferred from the claim text.